FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019939987> ?p ?o ?g. }

• W2019939987 endingPage "486" @default.
• W2019939987 startingPage "478" @default.
• W2019939987 abstract "Background Patients with diabetes have an increased risk of both developing and dying from cardiovascular disease, and, currently, more aggressive lipid-lowering targets are being recommended for these patients. Statins are widely and successfully used to correct dyslipidemia and prevent acute coronary episodes, but their effects on lipoprotein composition and peroxidation have not been fully investigated. We aimed to address this issue in type 1 diabetes mellitus. Methods T1DM patients with atherogenic index (total/HDL-cholesterol > 4) were randomised double-blindly to group A (n = 12) that received Atorvastatin 40 mg/day and group P (n = 12) that received placebo. They were monitored for blood biochemistry, LDL sub-fractions and lipid peroxidation at inclusion, after 6 and after 12 weeks. Results In group A, the 40% decrease in serum total and LDL cholesterol and 20% decrease in triglycerides was accompanied by a decrease in serum α-tocopherol from 46.4 ± 16.3 (mean ± SD) at inclusion to 32.2 ± 11.8 and 32.6 ± 14.0 µmol/L after 6 and 12 weeks respectively (p < 0.001 compared to group P by repeated-measures ANOVA). Relative to LDL + VLDL cholesterol, α-tocopherol increased by 40% (p < 0.001). Copper-induced LDL + VLDL peroxidation increased from 4891 ± 1325 at inclusion to 6821 ± 2291 and 7040 ± 1712 nmol TBARS/mg LDL + VLDL cholesterol produced in 3 h (p = 0.004). LDL sub-fractions shifted towards the less dense regions (p = 0.03). Conclusions These results suggest that Atorvastatin lowers the antioxidant capacity of LDL and VLDL in T1DM. The mechanisms underlying these changes merit further investigation and should be taken into account when planning long-term primary prevention of CHD in diabetes. Copyright © 2003 John Wiley & Sons, Ltd." @default.
• W2019939987 created "2016-06-24" @default.
• W2019939987 creator A5007578631 @default.
• W2019939987 creator A5019173777 @default.
• W2019939987 creator A5050747885 @default.
• W2019939987 creator A5065267600 @default.
• W2019939987 date "2003-01-01" @default.
• W2019939987 modified "2023-09-27" @default.
• W2019939987 title "Effects of Atorvastatin on LDL sub-fractions and peroxidation in type 1 diabetic patients: a randomised double-blind placebo-controlled study" @default.
• W2019939987 cites W1529592271 @default.
• W2019939987 cites W1953115230 @default.
• W2019939987 cites W1964781805 @default.
• W2019939987 cites W1964874366 @default.
• W2019939987 cites W1967172766 @default.
• W2019939987 cites W1983573843 @default.
• W2019939987 cites W1989357301 @default.
• W2019939987 cites W1990806051 @default.
• W2019939987 cites W1992153362 @default.
• W2019939987 cites W1994191432 @default.
• W2019939987 cites W1996210832 @default.
• W2019939987 cites W2002164965 @default.
• W2019939987 cites W2003382978 @default.
• W2019939987 cites W2007037504 @default.
• W2019939987 cites W2012254882 @default.
• W2019939987 cites W2018715171 @default.
• W2019939987 cites W2024995822 @default.
• W2019939987 cites W2027887123 @default.
• W2019939987 cites W2028401356 @default.
• W2019939987 cites W2028737407 @default.
• W2019939987 cites W2029127038 @default.
• W2019939987 cites W2031831221 @default.
• W2019939987 cites W2039261801 @default.
• W2019939987 cites W2041109111 @default.
• W2019939987 cites W2054404971 @default.
• W2019939987 cites W2059537042 @default.
• W2019939987 cites W2068423934 @default.
• W2019939987 cites W2072308694 @default.
• W2019939987 cites W2085050051 @default.
• W2019939987 cites W2085237225 @default.
• W2019939987 cites W2085369605 @default.
• W2019939987 cites W2090007062 @default.
• W2019939987 cites W2093561173 @default.
• W2019939987 cites W2093987460 @default.
• W2019939987 cites W2096010571 @default.
• W2019939987 cites W2096230450 @default.
• W2019939987 cites W2106536809 @default.
• W2019939987 cites W2114295374 @default.
• W2019939987 cites W2115337518 @default.
• W2019939987 cites W2115728877 @default.
• W2019939987 cites W2116404316 @default.
• W2019939987 cites W2121008706 @default.
• W2019939987 cites W2125847911 @default.
• W2019939987 cites W2138673524 @default.
• W2019939987 cites W2138961575 @default.
• W2019939987 cites W2143833093 @default.
• W2019939987 cites W2148459936 @default.
• W2019939987 cites W2158616656 @default.
• W2019939987 cites W2162642883 @default.
• W2019939987 cites W2164929678 @default.
• W2019939987 cites W2164941554 @default.
• W2019939987 cites W2244494985 @default.
• W2019939987 cites W2260235167 @default.
• W2019939987 cites W2331274940 @default.
• W2019939987 cites W2565229519 @default.
• W2019939987 cites W2975364463 @default.
• W2019939987 cites W424467158 @default.
• W2019939987 doi "https://doi.org/10.1002/dmrr.402" @default.
• W2019939987 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14648807" @default.
• W2019939987 hasPublicationYear "2003" @default.
• W2019939987 type Work @default.
• W2019939987 sameAs 2019939987 @default.
• W2019939987 citedByCount "11" @default.
• W2019939987 countsByYear W20199399872012 @default.
• W2019939987 countsByYear W20199399872015 @default.
• W2019939987 countsByYear W20199399872020 @default.
• W2019939987 countsByYear W20199399872021 @default.
• W2019939987 crossrefType "journal-article" @default.
• W2019939987 hasAuthorship W2019939987A5007578631 @default.
• W2019939987 hasAuthorship W2019939987A5019173777 @default.
• W2019939987 hasAuthorship W2019939987A5050747885 @default.
• W2019939987 hasAuthorship W2019939987A5065267600 @default.
• W2019939987 hasConcept C126322002 @default.
• W2019939987 hasConcept C134018914 @default.
• W2019939987 hasConcept C142724271 @default.
• W2019939987 hasConcept C204787440 @default.
• W2019939987 hasConcept C27081682 @default.
• W2019939987 hasConcept C2776151105 @default.
• W2019939987 hasConcept C2777352226 @default.
• W2019939987 hasConcept C2777482532 @default.
• W2019939987 hasConcept C2778096610 @default.
• W2019939987 hasConcept C2778163477 @default.
• W2019939987 hasConcept C2780072125 @default.
• W2019939987 hasConcept C2780829032 @default.
• W2019939987 hasConcept C555293320 @default.
• W2019939987 hasConcept C71924100 @default.
• W2019939987 hasConcept C8243546 @default.
• W2019939987 hasConcept C90924648 @default.
• W2019939987 hasConceptScore W2019939987C126322002 @default.

• next